Richard J. Edmondson

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Alicia León‐Castillo, Stephanie M. de Boer, Melanie Powell et al. · Journal of Clinical Oncology · 2020 · 777 citations · Full text

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

Ellen Stelloo, Tjalling Bosse, Remi A. Nout et al. · Modern Pathology · 2015 · 476 citations · Full text

Targetable Pathways, Transportec Initiative, High-risk Endometrial Cancer +10

Copy number signatures and mutational processes in ovarian carcinoma

Geoff Macintyre, Teodora Goranova, Dilrini De Silva et al. · Nature Genetics · 2018 · 433 citations · Full text

Somatic Variant, Tumor Heterogeneity, Pathology +2

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

Michelle Wilson, Éric Pujade-Lauraine, Daisuke Aoki et al. · Annals of Oncology · 2016 · 285 citations · Full text

Gynecological Surgery, Medicine, Gynecologic Cancer Intergroup +8

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 280 citations · Full text